Menu Close

Articles on COVID-19 vaccines and variants

Displaying 1 - 20 of 44 articles

The FDA advisory committee discussed vaccine safety, effectiveness of the current shots, potential seasonality of COVID-19 and more. wildpixel/iStock via Getty Images Plus

FDA advisory committee votes unanimously in favor of a one-shot COVID-19 vaccine approach – 5 questions answered

Many questions remain about next steps for US vaccine policy. But the FDA advisory panel’s hearty endorsement of a single-composition COVID-19 vaccine represents a pivotal step.
Millions of U.S. children between the ages of 6 months and 4 years will soon be eligible for COVID-19 shots. FatCamera/E+ via Getty Images

At last, COVID-19 shots for little kids – 5 essential reads

The FDA’s authorization of COVID-19 shots for children ages 6 months to 4 years will bring relief for millions of parents. Pending CDC endorsement, shots for this group will be available within days.
Viral surveillance and prediction may be key parts of figuring out what goes into a vaccine. Pexels Cover/500px via Getty Images

Future COVID-19 booster shots will likely need fresh formulations as new coronavirus variants of concern continue to emerge

A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.
Luis Ascui/AAP

What’s the ‘Indian’ variant responsible for Victoria’s outbreak and how effective are vaccines against it?

The COVID-19 variant responsible for Victoria’s latest outbreak is one of three Indian variant sub-types, which spreads more easily than the original strain. Here’s what we know so far.

Top contributors

More